Related Experiment Video
Updated: Oct 20, 2025

Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
End-of-Life Care Requires Caution with Use of Continuous Glucose Monitoring
Ray Wang1, Rebecca Foskey1, Rahul Barmanray1,2
1Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Parkville, Victoria, Australia.
Abstract:
Use of medical device technologies for diabetes mellitus, including continuous glucose monitoring devices, is becoming more frequently encountered in end-of-life care. Good communication is paramount to determine patient and carer preferences for if, when, and how blood glucose monitoring should occur in the end-of-life setting. We present two differing cases of how continuous glucose monitoring in an Australian setting impacted end-of-life care for the patients and their carers.
More Related Videos
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon
Continuous Renal Replacement Therapy
Continuing Care
Chronic Kidney Disease IV: Nursing Management
Diabetes Mellitus: Type 2 and Gestational

